Choi Jung Bum, Kim Dong-Il, Paik Hyun-June, Lee Seung Joo, Jung Chang Shin, Kang Seok Kyung, Jung Youn Joo, Kim Hyun Yul
Department of Surgery, Pusan National University Hospital, Busan, Korea.
Department of Surgery, Pusan National University Yangsan Hospital, Yangsan, Korea.
Korean J Clin Oncol. 2020 Dec;16(2):145-147. doi: 10.14216/kjco.20023. Epub 2020 Dec 31.
Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.
起源于甲状腺组织的分化型甲状腺癌(DTC)受促甲状腺激素(TSH)影响。对于DTC患者,通常建议在甲状腺切除术后进行TSH抑制治疗。一名57岁女性因存在手术并发症风险,对其复发的巨大淋巴结进行了TSH抑制治疗。TSH抑制治疗后,颈部巨大淋巴结出现反应并缩小。对她进行了144个月的随访。对于围手术期风险高的复发性DTC患者,TSH抑制治疗可被视为一种替代治疗选择。